Efavirenz
Formulations: - Oral > Solid: 600 mg tablet Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
MOQ: 1
Price on request
Catalogue
Browse procurement-ready healthcare products from trusted vendors across the Afya Chain marketplace.
All Products (Showing 432 out of 662)
Nevirapine
Formulations: - Oral > Liquid: 50 mg per 5 mL Oral > Solid > dispersible tablet: 50 mg Oral > Solid > tablet: 200 mg Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
MOQ: 1
Price on request
Abacavir
Formulations: - Oral > Solid: 300 mg tablet (as sulfate) Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
MOQ: 1
Price on request
Lamivudine
Formulations: - Oral > Liquid: 50 mg per 5 mL Oral > Solid: 150 mg tablet Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
MOQ: 1
Price on request
Tenofovir Disoproxil Fumarate
Formulations: - Oral > Solid: 300 mg tablet (equivalent to 245 mg tenofovir disoproxil) Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified - Contact with or exposure to human immunodeficiency virus - Chronic hepatitis B Source: EML workbook import
MOQ: 1
Price on request
Zidovudine
Formulations: - Parenteral > General injections > IV: 10 mg per mL in 20 mL vial solution for IV infusion Oral > Liquid: 50 mg per 5 mL Oral > Solid > tablet: 300 mg Oral > Solid > capsule: 250 mg Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
MOQ: 1
Price on request
Atazanavir + Ritonavir
Formulations: - Oral > Solid: 300 mg (as sulfate) + 100 mg tablet (heat stable) Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
MOQ: 1
Price on request
Darunavir
Formulations: - Oral > Solid: 75 mg; 400 mg; 600 mg; 800 mg Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
MOQ: 1
Price on request
Lopinavir + Ritonavir
Formulations: - Oral > Solid > tablet: 100 mg + 25 mg tablet (heat-stable); 200 mg + 50 mg tablet (heat-stable) Oral > Solid > dosage form: 40 mg + 10 mg Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
MOQ: 1
Price on request
Ritonavir
Formulations: - Oral > Solid: 25 mg tablet (heat stable); 100 mg tablet (heat stable) Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
MOQ: 1
Price on request
Arpraziquantel
Formulations: - Oral > Solid > dispersible tablet: 150 mg Indications: - Schistosomiasis Source: EML workbook import
MOQ: 1
Price on request
Oxamniquine
Formulations: - Oral > Liquid: 250 mg per 5 mL Oral > Solid > capsule: 250 mg Indications: - Schistosomiasis due to Schistosoma mansoni Source: EML workbook import
MOQ: 1
Price on request
Sign Up to Our Newsletter→
Ready to amplify your rewards? Drop your email and we'll be in touch soon.